Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Duolingo Inc (DUOL) vs Revvity Inc (RVTY) Price & Performance

Duolingo IncTrade
Revvity IncTrade

Price performance (Past 24H)

Key statistics

Duolingo Inc vs Revvity Inc — how do they compare? Duolingo Inc trades at $150.02 (market cap $7.08B), while Revvity Inc trades at $154.1 (market cap $16.98B). The key difference: Revvity Inc is far larger — about 2.4× Duolingo Inc's market cap, and Revvity Inc pays a 0.18% dividend while Duolingo Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Duolingo Inc for 137 Days and Revvity Inc for 12 Days on average.

DUOLRVTY
Market Cap
$7.08B$16.98B
Volume
729,1711,456,900
Sector
TechnologyHealth
52-Week High
$341.08$157.36
52-Week Low
$90.03$82.26
Typical Hold Time
137 Days12 Days
Enterprise Value
$5.85B$19.30B
Dividend Yield
—0.18%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Duolingo Inc

Duolingo (DUOL) trades at $151.16, down 0.37% on the day, as the stock consolidates near recent highs. The company demonstrates strong fundamental momentum with Q2 2026 EPS of $0.66 beating expectations of $0.604, marking the third consecutive quarterly beat. Revenue growth remains robust at 29% year-over-year, supported by a 36% net income margin. Technical indicators show a bullish trend with the stock trading above key support levels, though RSI suggests potential near-term overbought conditions.

Duolingo's outlook remains positive with accelerating revenue growth and expanding profitability, though the stock trades at a premium valuation with a P/E of 17.87. Key risks include CEO share sales and competitive pressures in the edtech space. Analyst consensus leans cautious with 37.5% buy ratings versus 54.2% hold, suggesting potential for re-rating if growth momentum continues.

Revvity Inc

RVTY trades at $155.01, up 0.92% with a bullish technical outlook. The stock shows strong earnings momentum with three consecutive quarterly beats and maintains solid profitability with 54.98% gross margins. Recent developments include new product launches in Europe and strategic acquisitions to expand metabolic disease research capabilities.

The investment case balances premium valuation (P/E 73.15) against consistent execution and growth initiatives. Key risks include China market pressures and margin compression, while analyst consensus remains positive with 52% buy ratings. Upside potential exists if Q3 earnings meet expectations in November.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DUOL
18% Buy82% Sell
Avg holding period · 137 Days
RVTY
0% Buy100% Sell
Avg holding period · 12 Days

Top news

Latest headlines on both assets

About Duolingo Inc

Duolingo Inc is a mobile learning platform to learn languages and the top-grossing app in the Education category on both Google Play and the Apple App Store. It has three predominant sources of revenue

Read more on DUOL →

About Revvity Inc

Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.

Read more on RVTY →